ExploreStudyPMC9637371
Study

PMC9637371

15 findings 1 paper 8 related entities View in graph →

Related entities

interventions
conditions
outcomes
populations

Findings (50)

None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among

Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)

Size: β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:
None
improvement

Physical activity most prominently modified the PFOA-cardiometabolic association for type 2 diabetes risk factors: PAQ-C scores significantly modified associations of PFOA with HOMA-IR, leptin:adipone

Effect: improvement; PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:adiponectin ratio, and visceral fat percent

Size: PAQ-C × PFOA interaction p-values <0.05 for HOMA-IR, leptin:

Papers (1)